The higher the number of immune cells (turquoise) that fight cancer cells (center), the greater the chance of tumour eradication. This is why scientists are looking for ways to administer additional immune cells to cancer patients. (Image: Adobe Stock)
The higher the number of immune cells (turquoise) that fight cancer cells ( center ), the greater the chance of tumour eradication. This is why scientists are looking for ways to administer additional immune cells to cancer patients. (Image: Adobe Stock) Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these. Edo Kapetanovic is a medical doctor, but for a while now he has devoted himself entirely to research in synthetic immunology. He has completed his doctoral studies in immunoengineering and is working at the Department of Biosystems Science and Engineering at ETH Zurich in Basel.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
